Livmarli (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
- RxCUI
- 2571085
- RxNorm name
- Livmarli (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
- Display name
- Livmarli (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
- Full name
- Livmarli (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Livmarli | MARALIXIBAT CHLORIDE | Mirum Pharmaceuticals Inc. | 64000394-1ef6-4e76-8ba8-11f25ba1b167 | 2025-04-10 | Warnings, Adverse reactions | 2571085 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 64000394-1ef6-4e76-8ba8-11f25ba1b167 | Livmarli 9.5 MG/mL Oral Solution [PSN] · maralixibat 9.5 MG/ML Oral Solution [Livmarli] [SBD] · Livmarli (as maralixibat chloride 10 MG/ML) 9.5 MG/ML Oral Solution [SY] | 3 | 11 | These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 2021 | 20250410 |